Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Abdominal Cancer × Influenza Vaccines × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Abdominal Cancer 1

Interventions

Tadalafil 1 Influenza Vaccines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02998736 2022-12-28

PERIOP-04

Ottawa Hospital Research Institute

Phase 1 Completed

Abdominal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡